2021-01-13 14:51:32 EXAS Exact Sciences
01/13/21 01/1314:51 01/13/2114:51 | Exact Sciences reports worldwide exclusive license for TARDIS technologyExact Sciences announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from The Translational Genomics Research Institute, or "TGen," an affiliate of City of Hope. "This compelling and technically distinct approach will help expand Exact Sciences' leadership in precision oncology and offers a differentiated patient-specific solution in minimal residual disease testing," the company stated. Kevin Conroy, chairman and CEO of Exact Sciences, added: "Exact Sciences is uniquely positioned to lead cancer diagnostics with our broad foundation and the talented team that created Cologuard and Oncotype DX. We're excited to work with TGen and City of Hope to bring the incredible TARDIS technology to physicians and patients and deliver a better solution in minimal residual disease to improve cancer patient outcomes." | |
---|---|---|
|
Hot Stocks
|
Resolute Forest names Sylvain Girard as CFO »
18:03 01/18/21 01/1818:03 01/18/2118:03
RFP
Resolute Forest
Resolute Forest Products… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
KLA Corp. price target raised to $308 from $271 at Goldman Sachs »
18:01 01/18/21 01/1818:01 01/18/2118:01
KLAC
KLA Corp.
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Entegris price target raised to $116 from $102 at Goldman Sachs »
17:59 01/18/21 01/1817:59 01/18/2117:59
ENTG
Entegris
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Teradyne price target raised to $150 from $128 at Goldman Sachs »
17:58 01/18/21 01/1817:58 01/18/2117:58
TER
Teradyne
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Lam Research price target raised to $616 from $557 at Goldman Sachs »
17:58 01/18/21 01/1817:58 01/18/2117:58
LRCX
Lam Research
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Applied Materials price target raised to $118 from $99 at Goldman Sachs »
17:57 01/18/21 01/1817:57 01/18/2117:57
AMAT
Applied Materials
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
CMC Materials upgraded to Neutral from Sell at Goldman Sachs »
17:57 01/18/21 01/1817:57 01/18/2117:57
CCMP
CMC Materials
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Alimentation downgraded to Market Perform from Outperform at BMO Capital »
17:52 01/18/21 01/1817:52 01/18/2117:52
ANCUF
Alimentation Couche-Tard
Carrefour
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
American Campus announces quarterly dividend of 47c »
17:49 01/18/21 01/1817:49 01/18/2117:49
ACC
American Campus
American Campus… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Canada scrambles to salvage Keystone XL, Reuters reports »
17:23 01/18/21 01/1817:23 01/18/2117:23
TRP
TC Energy
U.S. President-elect Joe… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
NY Gov. asks Pfizer to directly sell COVID vaccine doses, Reuters reports »
17:19 01/18/21 01/1817:19 01/18/2117:19
PFE
Pfizer
New York Governor Andrew… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
First Majestic to host conference call »
16:24 01/18/21 01/1816:24 01/18/2116:24
AG
First Majestic
Management discusses 4Q… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
CommScope files patent infringement suit against SOLiD in Germany »
16:17 01/18/21 01/1816:17 01/18/2116:17
COMM
CommScope
CommScope filed an… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Fly Intel: What to watch in next round of big banks' earnings reports »
16:09 01/18/21 01/1816:09 01/18/2116:09
BAC
Bank of America
Goldman Sachs
Morgan Stanley
Goldman Sachs (GS) and… Goldman Sachs (GS) and Bank of America (BAC) are scheduled to announce quarterly results on January 19, while Morgan Stanley (MS) is expected to report on January 20. What to watch for: 1. SELECT OPPORTUNITIES AMONG BANKS: Last week, Citi analyst Keith Horowitz upgraded Bank of America to Buy from Neutral with a price target of $37, up from $31. A steeper curve "should be more readily evident with lower premium am, in addition to securities yield lift," Horowitz told investors in a research note. The analyst sees select opportunities among the banks. Those banks that have outperformed this year aren't the banks that stand to benefit the most from a steeper curve, creating opportunities, he added. 2. POSITIVE EARNINGS SURPRISES: Earlier this month, Barclays analyst Jason Goldberg upgraded Morgan Stanley to Overweight from Equal Weight with a price target of $88, up from $60. The analyst told investors that he expects Morgan Stanley to continue to benefit from positive earnings surprises, "relatively more aggressive" capital returns and improving revenue durability. While trading comps will likely be tough in 2021, results should "remain elevated," while investment banking activity remains heightened, Goldberg contended. Citing similar reasons, the analyst also upgraded Goldman Sachs to Overweight from Equal Weight with a price target of $362, up from $270. 3. 1MDB SETTLEMENT: In a regulatory filing back in October, Goldman Sachs Group announced that it had reached settlements of governmental and regulatory investigations relating to 1Malaysia Development Berhad, or 1MDB, with the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the Board of Governors of the Federal Reserve System, the New York State Department of Financial Services, the U.K. Financial Conduct Authority, the U.K. Prudential Regulation Authority, the Singapore Attorney General's Chambers, the Singapore Commercial Affairs Department, the Monetary Authority of Singapore and the Hong Kong Securities and Futures Commission. Goldman Sachs agreed to enter into a three-year deferred prosecution agreement with the DOJ, in which a charge against the firm, one count of conspiracy to violate the Foreign Corrupt Practices Act of 1977, will be filed and later dismissed if the firm abides by the terms of the agreement. In addition, Group Inc.'s subsidiary in Malaysia, GS Malaysia, has agreed to plead guilty to one count of conspiracy to violate the FCPA. The company will pay total penalties, after crediting, of approximately $2.6B in connection with the settlements. A separate obligation to pay $606M in disgorgement has been credited and satisfied as a result of the firm's earlier settlement with the Government of Malaysia, in which the company paid a total of $2.5B, in addition to providing a $1.4B asset recovery guarantee. This brings the total payments in connection with governmental and regulatory settlements relating to 1MDB to an aggregate of approximately $5.1B. 4. SHARE REPURCHASES: Back in December, Goldman Sachs said in a statement that, "We are pleased that the results of the Federal Reserve's latest stress test demonstrate the resilience of the largest U.S. financial institutions in the midst of a devastating pandemic. Based on the results and guidance from the Federal Reserve, we intend to resume share repurchases next quarter. In the meantime, we will continue to serve our clients and help them navigate a challenging economic environment." During its last earnings conference call, Morgan Stanley had also said that it sees resuming buybacks in the first quarter 2021. ShowHide Related Items >><<
|
Hot Stocks
|
Chart Industries announces transfer from Nasdaq to NYSE »
16:01 01/18/21 01/1816:01 01/18/2116:01
GTLS
Chart Industries
Chart Industries… Chart Industries announced that it intends to transfer the listing of its common stock to the New York Stock Exchange from the Nasdaq stock exchange effective February 1, 2021. Chart's common stock will continue to trade under the ticker symbol GTLS. "We are pleased to join the NYSE, the world's largest stock exchange with world-class listed companies, to further reach global investors and shareholders," stated Jill Evanko, Chart's CEO and President. "With four of our top five customers also listed on the NYSE, we believe this will enhance our exposure to them and further develop new and existing partnerships." ShowHide Related Items >><<
|
Periodicals
|
Tesla says Model Y deliveries in China have officially begun »
15:45 01/18/21 01/1815:45 01/18/2115:45
TSLA
Tesla
Tesla announced via… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Lumentum in advanced talks to acquire Coherent, WSJ reports »
15:42 01/18/21 01/1815:42 01/18/2115:42
COHR
Coherent
Lumentum
Lumentum Holdings (LITE)… Lumentum Holdings (LITE) is in advanced talks to acquire Coherent (COHR) in a cash-and-stock deal that could come together as soon as this week, Cara Lombardo of Wall Street Journal reports, citing people familiar with the matter. Exact terms couldn't be learned, Lombardo adds. Reference Link ShowHide Related Items >><<
|
Hot Stocks
|
Air Canada to resume Boeing 737 MAX commercial operations on Feb. 1 »
13:11 01/18/21 01/1813:11 01/18/2113:11
ACDVF
Air Canada
Boeing
Air Canada (ACDVF) said… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Tesco reinstated with a Buy at Goldman Sachs »
13:09 01/18/21 01/1813:09 01/18/2113:09
TSCDY
Tesco
Goldman Sachs analyst Rob… Goldman Sachs analyst Rob Joyce reinstated coverage of Tesco with a Buy rating and 295 GBp price target. With the "broadest and cheapest" entry level pricing in the U.K., alongside the lowest cost to serve online orders, Tesco is well positioned to hold onto share gained from the discounters in 2020, while growing profits, Joyce tells investors in a research note. ShowHide Related Items >><<
|
Hot Stocks
|
Biohaven's troriluzole did not differentiate from placebo in Alzheimer's trial »
13:06 01/18/21 01/1813:06 01/18/2113:06
BHVN
Biohaven Pharmaceutical
Biohaven Pharmaceutical… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Granite announces $20M contact by California Department of Transportation »
13:02 01/18/21 01/1813:02 01/18/2113:02
GVA
Granite
Granite announced that it… Granite announced that it has been awarded a $20M contract by the California Department of Transportation for the State Route 46 4-Lane Widening Project in Lost Hills, California. The contract is anticipated to be included in Granite's first quarter 2021 backlog. The project widens State Route 46 from a two-lane to a four-lane highway between post miles 29.7 and 31.9 in Kern County. Scope of work includes the construction of two new lanes, a bridge over the California Aqueduct, a high-intensity activated crosswalk beacon at the State Route 46/Bruning Avenue intersection, a large drainage basin on the west side of Lost Hills Road, as well as curb, gutter, and crosswalks throughout the town of Lost Hills. ShowHide Related Items >><<
|
Hot Stocks
|
Equinox announces positive drill results from Piaba Underground target »
13:00 01/18/21 01/1813:00 01/18/2113:00
EQX
Equinox Gold
Equinox Gold announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
AstraZeneca, Daiichi announce FDA approval of Enhertu for gastric cancer »
12:58 01/18/21 01/1812:58 01/18/2112:58
AZN
AstraZeneca
AstraZeneca and Daiichi… AstraZeneca and Daiichi Sankyo said Enhertu has been approved in the U.S. for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma who have received a prior trastuzumab-based regimen. The approval by the Food and Drug Administration was based on the positive results from the randomized DESTINY-Gastric01 Phase II trial conducted in Japan and South Korea. Enhertu is approved with Boxed Warnings for interstitial lung disease or pneumonitis and embryo-fetal toxicity. This is the second indication approved for Enhertu in the U.S. following the accelerated approval for adult patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting based on the DESTINY-Breast01 trial. ShowHide Related Items >><<
|
Hot Stocks
|
Quest enters agreement with CDC for genomic sequencing of Covid variants »
12:56 01/18/21 01/1812:56 01/18/2112:56
DGX
Quest Diagnostics
Quest Diagnostics… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Reliance Steel promotes Karla Lewis to President, names Arthur Ajemyan CFO »
12:46 01/18/21 01/1812:46 01/18/2112:46
RS
Reliance Steel
Reliance Steel &… Reliance Steel & Aluminum announced that Karla Lewis has been promoted to President and appointed to the company's board. Prior to being named President, Lewis served as Senior Executive Vice President and Chief Financial Officer. In concert with Lewis' promotion, Reliance also announced the promotion of Arthur Ajemyan to Vice President, Chief Financial Officer effective January 15. Ajemyan became Vice President, Corporate Controller in May 2014. ShowHide Related Items >><<
|